Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filings

Filing date Description Form Filing Group Issuer View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

424B4
Registration Statements
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Registration of up to an additional 20% of securities for an offering filed on an F-1

F-1MEF
Registration Statements
View HTML

EFFECT

EFFECT
Other
View HTML

This filing is a pre-effective amendment to an F-1 filing

F-1/A
Registration Statements
View HTML

FWP

FWP
Other
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Registration statement for certain foreign private issuers

F-1
Registration Statements
View HTML

Copyright Morningstar